These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 7453677

  • 21. (+)-Cyanidanol-3 in acute viral hepatitis.
    Di Nola F.
    Lancet; ; 2(8208-8209):1379-80. PubMed ID: 6109203
    [No Abstract] [Full Text] [Related]

  • 22. (+)-cyanidanol-3.
    Lancet; 1982 Mar 06; 1(8271):549. PubMed ID: 6120400
    [No Abstract] [Full Text] [Related]

  • 23. ["Catergen" in the treatment of hepatitis].
    Gładysz A, Juszczyk J.
    Wiad Lek; 1985 Jul 15; 38(14):1039-42. PubMed ID: 3907149
    [No Abstract] [Full Text] [Related]

  • 24. Effect of (+)-cyanidanol-3 on chronic active hepatitis: a double blind controlled trial.
    Bar-Meir S, Halpern Z, Gutman M, Shpirer Z, Baratz M, Bass D.
    Gut; 1985 Sep 15; 26(9):975-9. PubMed ID: 3896964
    [Abstract] [Full Text] [Related]

  • 25. [Clinical analysis of 4 cases of severe viral hepatitis treated with catergen].
    Rzeszowska G, Modrzewska R, Radomińska I.
    Wiad Lek; 1980 May 01; 33(9):739-43. PubMed ID: 7405243
    [No Abstract] [Full Text] [Related]

  • 26. [Observations on the use of catergen (Zyma) in the treatment of hepatic coma].
    Rzeszowska G, Mierzejewska I, Patorska-Mach E.
    Wiad Lek; 1980 Nov 15; 33(22):1831-5. PubMed ID: 7210679
    [No Abstract] [Full Text] [Related]

  • 27. [Effect of silymarin and (+)-cyanidanol-3 on hexachlorobenzene(HCB)-induced porphyria in rats].
    Siegers CP.
    Z Gastroenterol; 1982 Dec 15; 20(12):757-8. PubMed ID: 7164529
    [No Abstract] [Full Text] [Related]

  • 28. [A contribution as to the effect of (+)-Cyanidanol-3 in chronic liver disease (author's transl)].
    Sondern W, Leube G.
    Med Klin; 1978 Oct 13; 73(41):1432-6. PubMed ID: 703670
    [Abstract] [Full Text] [Related]

  • 29. Effects of (+)-cyanidanol-3.
    Lancet; 1982 Mar 27; 1(8274):737. PubMed ID: 6122024
    [No Abstract] [Full Text] [Related]

  • 30. [The value of Catergen].
    Orv Hetil; 1983 Jun 05; 124(23):1411-2. PubMed ID: 6877819
    [No Abstract] [Full Text] [Related]

  • 31. Cyanidanol: will a hepatotrophic drug from Europe go west?
    Hepatology; 1983 Jun 05; 3(1):121-3. PubMed ID: 6822375
    [No Abstract] [Full Text] [Related]

  • 32. [Values of haptoglobins, total protein, alpha2-globulins and 5'- nucleotidases in acute viral hepatitis in relation to the treatment used].
    Radomińska I, Rzeszowska G, Fijałka-Rymar M, Borowicz I.
    Ann Univ Mariae Curie Sklodowska Med; 1985 Jun 05; 40():95-9. PubMed ID: 2856012
    [No Abstract] [Full Text] [Related]

  • 33. [Clinical study of the therapeutic action of silymarin in acute infectious hepatitis in childhood].
    Mingrino F, Tosti U, Anania S, Buglioni MC, Viola F.
    Minerva Pediatr; 1979 Mar 31; 31(6):451-6. PubMed ID: 470888
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Prognosis of prolonged hepatitis in childhood].
    Scholz H.
    Kinderarztl Prax; 1976 Dec 31; 44(12):529-35. PubMed ID: 1011548
    [No Abstract] [Full Text] [Related]

  • 38. [Effect of complex treatment using potassium orotate on the non-specific immunologic reactivity of children with viral hepatitis].
    Bogatyreva SO.
    Pediatr Akus Ginekol; 1976 Dec 31; (6):15-7. PubMed ID: 1025506
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. [Use of sodium nucleinate in the overall therapy of viral hepatitis in children].
    Frolov VM, Razenkova AT.
    Vopr Okhr Materin Det; 1980 Sep 31; 25(9):12-5. PubMed ID: 6158790
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.